The Battle Of The Bulge
The Nattering Naybob - at Seeking Alpha - Mon May 18, 8:59AM CDT
ABT: 48.84 (+0.13), PFE: 33.98 (-0.01), SYY: 37.49 (+0.22), LO: 71.83 (-0.33), LLY: 72.94 (+0.04), MDRX: 14.08 (+0.10), BMY: 68.00 (+0.36), GSK: 44.66 (-0.11), MO: 51.95 (-0.87), ATHN: 120.85 (+0.76), PM: 86.03 (-0.54), JNJ: 103.42 (+1.12), GILD: 111.00 (+1.70), AAC: 37.65 (+0.64), MRK: 60.01 (-0.22), AZN: 68.74 (-0.55), WTW: 6.59 (-0.59), NVS: 104.06 (+0.31)
The Weekender
Aviate - at Seeking Alpha - Sun May 17, 7:39AM CDT
Rising rates, banks, beta and the pain trade We note a strategy piece by a well-respected strategist this week (JPMorgan) used the word ' reflation ' - one all but removed from investment parlance - with respect to the bond market's rather vicious...
WMT: 79.92 (+0.68), RBS: 11.05 (-0.08), SPY: 213.10 (+0.66), LYG: 5.53 (-0.10), AV: 16.76 (-0.34), MR: 27.37 (-0.19), PSO: 20.90 (+0.06), LBTYK: 49.67 (+0.24), TI: 12.31 (-0.22), LBTYA: 51.94 (+0.34), BHP: 48.37 (-3.18), TEF: 14.72 (-0.16), DIA: 182.68 (+0.20), ING: 16.37 (-0.22), RIO: 45.64 (-0.49), PHG: 27.91 (-0.42), VOD: 36.51 (-0.53), QQQ: 110.06 (+0.48)
Novartis Sees Past Lucentis's Decline
EP Vantage - Seeking Alpha - Wed Mar 04, 9:21AM CST
Having been outmanoeuvred first on price and then on dosing, Novartis (NYSE: NVS ) is preparing its next line of defence in macular degeneration as sales of its flagship Lucentis plateau. A phase II trial has shown that RTH258 is the equal of ...
REGN: 496.74 (+7.73), NVS: 104.06 (+0.31)
TiGenix: Locked And Loaded For Phase 3 Readout
Logribel Biostocks - at Seeking Alpha - Mon Mar 02, 11:30AM CST
GRFS: 32.88 (+0.04), NVS: 104.06 (+0.31)
Flexus Shows Other Immuno-Oncology Wannabes How It's Done
EP Vantage - Seeking Alpha - Wed Feb 25, 1:28PM CST
Deal making in the immuno-oncology space was always going to be a big theme of 2015, and Bristol-Myers Squibb ’s (NYSE: BMY ) moves yesterday – most notably the $800m it paid to secure Flexus Biosciences ’ preclinical...
MRK: 60.01 (-0.22), INCY: 107.65 (+0.79), NLNK: 40.05 (+0.36), BMY: 68.00 (+0.36)
Why Don't You Diversify Your Portfolio With Some European Blue Chips?
Gold Finder - at Seeking Alpha - Fri Jan 23, 9:50AM CST
UN: 43.42 (-0.38), HSBC: 48.45 (-0.36), GOOG: 532.30 (-1.55), T: 34.87 (+0.54), BRK.A: 219,125.30 (+485.30), NVS: 104.06 (+0.31)
Week In Review: Roche Seeks China Partners With First-In-Class, Best-In-Class Products
ChinaBio Today - at Seeking Alpha - Sun Oct 26, 12:46PM CDT
Featured Companies In an exclusive interview, Dr. Darren Ji (Vice President and Global Head of Roche Partnering, Asia and Emerging Markets) told ChinaBio Today that Roche ( OTCQX:RHHBY ) ( OTCPK:RHHBF ) remains entirely focused on novel drugs for...
FMI: 35.49 (-1.60), AKER: 4.05 (+0.12), WX: 43.19 (-0.15)